SciClone Pharmaceuticals (6600.HK)
Company Info
| ISIN | KYG4271B1023 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
Highlights
| Market Cap | HK$9.87B |
|---|---|
| PE Ratio | 10.42 |
| Revenue (TTM) | HK$2.88B |
| Gross Profit (TTM) | HK$2.07B |
| EBITDA (TTM) | HK$1.32B |
| Year Range | HK$8.75 - HK$16.10 |
| Target Price | HK$14.64 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in SciClone Pharmaceuticals, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
SciClone Pharmaceuticals had a return of 29.31% year-to-date (YTD) and 58.84% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 29.31% | 5.90% |
| 1 month | 28.21% | -1.28% |
| 6 months | 86.14% | 15.51% |
| 1 year | 58.84% | 21.68% |
| 5 years (annualized) | N/A | 11.74% |
| 10 years (annualized) | N/A | 10.50% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -20.26% | 17.30% | 23.20% | |||||||||
| 2023 | 5.60% | 3.10% | 32.04% | 2.35% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
SciClone Pharmaceuticals(6600.HK)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for SciClone Pharmaceuticals (6600.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
SciClone Pharmaceuticals granted a 2.17% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.39 per share.
| Period | TTM | 2023 | 2022 |
|---|---|---|---|
| Dividend | HK$0.39 | HK$0.39 | HK$0.35 |
Dividend yield | 2.17% | 2.80% | 4.22% |
Monthly Dividends
The table displays the monthly dividend distributions for SciClone Pharmaceuticals. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | |||||||||
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.39 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| 2022 | HK$0.35 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the SciClone Pharmaceuticals. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the SciClone Pharmaceuticals was 68.49%, occurring on Oct 28, 2022. Recovery took 349 trading sessions.
The current SciClone Pharmaceuticals drawdown is 0.22%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -68.49% | Mar 4, 2021 | 409 | Oct 28, 2022 | 349 | Apr 2, 2024 | 758 |
| -0.45% | Apr 8, 2024 | 2 | Apr 9, 2024 | 3 | Apr 12, 2024 | 5 |
| -0.33% | Apr 3, 2024 | 1 | Apr 3, 2024 | 1 | Apr 5, 2024 | 2 |
| -0.22% | Apr 16, 2024 | 1 | Apr 16, 2024 | — | — | — |
Volatility
Volatility Chart
The current SciClone Pharmaceuticals volatility is 17.04%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |